Literature DB >> 30176055

A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.

Sujith Prasad W Kumarasinghe1, Amit Pandya2, Veena Chandran3, Michelle Rodrigues4, Ncoza C Dlova5, Hee Young Kang6, M Ramam7, Johannes F Dayrit8, Boon Kee Goh9, Davinder Parsad10.   

Abstract

Ashy dermatosis (AD), lichen planus pigmentosus (LPP), erythema dyschromicum perstans (EDP), and idiopathic eruptive macular pigmentation are several acquired macular hyperpigmentation disorders of uncertain etiology described in literature. Most of the published studies on these disorders are not exactly comparable, as there are no clear definitions and different regions in the world describe similar conditions under different names. A consensus on the terminology of various morphologies of acquired macular pigmentation of uncertain etiology was a long-felt need. Several meetings of pigmentary disorders experts were held to address this problem. A consensus was reached after several meetings and collation of e-mailed questionnaire responses and e-mail communications among the authors of publications on the above conditions. This was achieved by a global consensus forum on AD, LPP, and EDP, established after the 22nd International Pigment Cell Conference held in Singapore in 2014. Thirty-nine experts representing 18 countries participated in the deliberations. The main focus of the deliberations was terminology of the conditions; as such, we present here the consensus statement of the forum and briefly review the available literature on the subject. We have not attempted to discuss treatment modalities in detail.
© 2018 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2018        PMID: 30176055     DOI: 10.1111/ijd.14189

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Psychosocial burden of lichen planus pigmentosus is similar to vitiligo, but greater than melasma: A cross-sectional study from a tertiary-care center in north India.

Authors:  Vishal Gupta; Deepika Yadav; Sujata Satapathy; Ashish Upadhyay; Soniya Mahajan; M Ramam; Vinod Kumar Sharma
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

2.  Insights into Lichen Planus Pigmentosus Inversus using Minimally Invasive Dermal Patch and Whole Transcriptome Analysis.

Authors:  Jacob Dickman; Michael Howell; Robert Hoopes; Yipeng Wang; Tobin J Dickerson; Michael Bottomley; H Nicholas Shamma; Christine M Rapp; Matthew J Turner; Craig A Rohan; Jeffrey B Travers
Journal:  J Clin Investig Dermatol       Date:  2022-04-05

3.  Lichen Planus Pigmentosus: A Clinico-etiological Study.

Authors:  Vibhu Mendiratta; Sarita Sanke; Ram Chander
Journal:  Indian Dermatol Online J       Date:  2019 May-Jun

4.  Proton pump inhibitor-induced erythema dyschromicum perstans-like pigmentation.

Authors:  Daniel Gutierrez; Loren D Krueger; Andrea Tan; Joyce H Park; George Lipkin; Shane A Meehan
Journal:  JAAD Case Rep       Date:  2019-08-05

5.  Osimertinib-associated ashy dermatosis-like hyperpigmentation.

Authors:  Pattamon Lertpichitkul; Jade Wititsuwannakul; Pravit Asawanonda; Pawinee Rerknimitr
Journal:  JAAD Case Rep       Date:  2020-01-17

6.  Riehl's Melanosis: A Multimodality, In Vivo, Real-Time Skin Imaging Study with Cellular Resolution Optical Coherence Tomography and Advanced Skin Diagnosis System in a Tertiary Medical Center.

Authors:  Peng-Chieh Shen; Yu-Pei Chan; Chun-Hsien Huang; Chau Yee Ng
Journal:  Bioengineering (Basel)       Date:  2022-08-26

7.  Histological Evaluation of Acquired Dermal Macular Hyperpigmentation.

Authors:  Sarita Sasidharanpillai; Aparna Govindan; Kidangazhi Yathmana Ajithkumar; Saranya T Mahadevan; Valiyaveettil Bindu; Anza Khader; Puthen Parambath Sathi
Journal:  Indian Dermatol Online J       Date:  2019-08-28

8.  Ashy Dermatosis and Lichen Planus Pigmentosus: The Histopathological Differences.

Authors:  Suthinee Rutnin; Siriorn Udompanich; Nathathai Pratumchart; Sarawin Harnchoowong; Vasanop Vachiramon
Journal:  Biomed Res Int       Date:  2019-10-28       Impact factor: 3.411

9.  Combination therapy with prednisone and isotretinoin in early erythema dyschromicum perstans: A retrospective series.

Authors:  Aisleen Diaz; Ryan Gillihan; Kiran Motaparthi; Adam Rees
Journal:  JAAD Case Rep       Date:  2020-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.